News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,508 Results
Type
Article (2584)
Company Profile (45)
Press Release (37878)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14279)
Career Advice (78)
Deals (2124)
Drug Delivery (9)
Drug Development (4252)
Employer Resources (10)
FDA (447)
Job Trends (782)
News (20478)
Policy (1066)
Tag
Academia (144)
Allergies (7)
Alliances (3516)
ALS (6)
Alzheimer's disease (87)
Antibody-drug conjugate (ADC) (27)
Approvals (449)
Artificial intelligence (32)
Autoimmune disease (8)
Automation (2)
Bankruptcy (12)
Best Places to Work (477)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (7)
Breast cancer (44)
Cancer (324)
Cardiovascular disease (11)
Career advice (66)
Career pathing (1)
CAR-T (31)
CDC (1)
Cell therapy (81)
Cervical cancer (2)
Clinical research (3543)
Collaboration (199)
Company closure (2)
Compensation (104)
COVID-19 (185)
CRISPR (11)
C-suite (112)
Cystic fibrosis (7)
Data (429)
Denatured (6)
Depression (11)
Diabetes (17)
Diagnostics (489)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (36)
Drug pricing (10)
Duchenne muscular dystrophy (40)
Earnings (4553)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6493)
Executive appointments (134)
FDA (592)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (167)
Gene editing (32)
Generative AI (1)
Gene therapy (55)
GLP-1 (65)
Government (158)
Guidances (24)
Healthcare (708)
HIV (1)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Immuno-oncology (14)
Indications (4)
Infectious disease (197)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (25)
Interviews (7)
IPO (1008)
IRA (7)
Job creations (293)
Job search strategy (62)
JPM (4)
Kidney cancer (6)
Labor market (11)
Layoffs (51)
Leadership (3)
Legal (216)
Liver cancer (6)
Longevity (1)
Lung cancer (28)
Lymphoma (12)
Machine learning (3)
Management (4)
Manufacturing (52)
MASH (14)
Medical device (315)
Medtech (316)
Mergers & acquisitions (1231)
Metabolic disorders (72)
Multiple sclerosis (22)
Neurodegenerative disease (28)
Neuropsychiatric disorders (10)
Neuroscience (194)
NextGen: Class of 2026 (354)
Non-profit (155)
Now hiring (11)
Obesity (32)
Opinion (17)
Ovarian cancer (17)
Pain (24)
Pancreatic cancer (21)
Parkinson's disease (11)
Partnered (4)
Patents (53)
Patient recruitment (26)
Peanut (1)
People (5890)
Pharmaceutical (5)
Phase 1 (1501)
Phase 2 (1752)
Phase 3 (947)
Pipeline (396)
Policy (16)
Postmarket research (33)
Preclinical (657)
Press Release (2)
Prostate cancer (7)
Psychedelics (3)
Radiopharmaceuticals (15)
Rare diseases (63)
Real estate (425)
Recruiting (5)
Regulatory (924)
Reports (7)
Research institute (151)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (16)
Series A (46)
Series B (20)
Service/supplier (2)
Sickle cell disease (4)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (497)
Stomach cancer (2)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (52)
Venture capital (15)
Weight loss (21)
Women's health (10)
Worklife (1)
Date
Last 7 days (40)
Last 30 days (155)
Last 365 days (2442)
2026 (215)
2025 (2468)
2024 (2656)
2023 (2874)
2022 (3758)
2021 (4054)
2020 (3515)
2019 (2086)
2018 (1571)
2017 (1838)
2016 (1635)
2015 (1872)
2014 (1395)
2013 (1204)
2012 (1403)
2011 (1343)
2010 (1191)
Location
Africa (44)
Alabama (3)
Arizona (18)
Asia (1960)
Australia (307)
California (1607)
Canada (241)
China (80)
Colorado (54)
Connecticut (16)
Delaware (5)
Europe (4036)
Florida (65)
Georgia (12)
Hawaii (2)
Idaho (3)
Illinois (21)
India (2)
Indiana (60)
Japan (17)
Kansas (14)
Kentucky (1)
Maryland (86)
Massachusetts (570)
Michigan (14)
Minnesota (22)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (134)
New York (80)
North Carolina (131)
Northern California (787)
Ohio (44)
Oklahoma (2)
Oregon (6)
Pennsylvania (109)
Puerto Rico (2)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (652)
Tennessee (4)
Texas (152)
United States (3251)
Utah (5)
Virginia (11)
Washington D.C. (3)
Washington State (95)
West Virginia (1)
Wisconsin (13)
40,508 Results for "tgr biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IGC Pharma Announces Preclinical Data Demonstrating TGR-63’s Dual Action on Alzheimer’s Pathology
September 25, 2025
·
3 min read
BioCapital
Promising Results: TGR-63 Enhances Memory in Alzheimer’s Mouse Model
IGC Pharma, Inc. announced the results of preclinical studies investigating its drug candidate TGR-63 as a treatment for Alzheimer’s disease.
February 28, 2024
·
5 min read
Drug Development
IGC Pharma’s TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer’s Disease
IGC Pharma, Inc. (NYSE American: IGC) (“IGC” or the “Company”) today announced encouraging preclinical results in an Alzheimer’s mouse model demonstrating the potential of the Company’s therapeutic candidate, TGR-63, to combat Alzheimer’s disease.
June 25, 2024
·
4 min read
BioCapital
IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer’s Mouse Model
IGC Pharma, Inc. (“IGC Pharma,” “IGC,” or the “Company”) (NYSE American: IGC) today announced additional positive results of preclinical studies investigating the Company’s newly announced therapeutic candidate, TGR-63, a potential treatment for Alzheimer’s disease.
February 1, 2024
·
5 min read
Drug Development
IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s
IGC Pharma, Inc. (“IGC Pharma,” “IGC,” or the “Company”) (NYSE American: IGC) provides details on its drug candidate TGR-63, which targets amyloid-beta plaque and can potentially improve Alzheimer’s disease treatment in a significant manner.
January 23, 2024
·
4 min read
Press Releases
Change in Number of Shares and Votes in Alligator Bioscience AB
February 1, 2026
·
1 min read
Press Releases
Imbed Biosciences Secures Strategic Investment from BioLab Holdings
February 4, 2026
·
2 min read
Press Releases
Invitation to Alligator Bioscience’s Earnings Call on 12 February 2026
February 5, 2026
·
1 min read
Press Releases
Genflow Biosciences PLC Announces Directorate Change
January 19, 2026
·
6 min read
Press Releases
Think Bioscience Raises $55M in Oversubscribed Series A
January 21, 2026
·
2 min read
1 of 4,051
Next
